KAIST 생명과학과동창회
  • News & Events
  • News

News

Growing up curious in the countryside leads to tools for manipulating endogenous proteins.

 

 

허원도 교수님 사진.jpg



Won Do Heo

“Good ideas come to me when I am very comfortable, when I am very happy,” says Won Do Heo, who is on the biology faculty at Korea Advanced Institute of Science and Technology (KAIST), and is a neuroscience fellow at the Institute for Basic Science, both in Daejon, Republic of Korea. An idea might come to him in a lab conversation, at a seminar or conference, when he is jogging, on one of his daily walks on a hill, or in the sauna at home.

 

It was a Korean national holiday and Heo was alone in the lab, thinking. He had spent a decade developing and using optogenetic tools. Suddenly, he realized how he might finally turn intrabodies, which are antibodies used to study intracellular proteins, into inducible tools.

 

Heo and his lab converted the idea into two classes of tools to target and manipulate proteins inside cells: optobodies, which can be activated by light; and chemobodies, which can be activated by small molecules. These tools leverage nanobodies, based on camelid antibodies, that are prized in cell biology for being soluble and small they’re around half the size of a green fluorescent protein molecule.

 

During that holiday musing, Heo had figured out at which cysteine residues he could split the nanobody to generate two inactive parts that do not bind a targeted protein. He checked the nanobody structure, and experiments got underway. The split structure lets an experimenter use light to, for example, activate or inhibit a protein at the cell membrane, at an organelle or in the cell nucleus. When the nanobody halves are separate, it’s like having only one chopstick for a meal, he says. Work only gets done when the other half enters the scene.

 

The tools offer high-resolution temporal and spatial information about endogenous proteins, says Heo. With optobodies, light can help with manipulating a targeted protein and thus shape cell function. The team’s chemobody would be good for an in vivo experiment, he says. Such studies, for example in neurobiology, are on his to-do list.

 

The lab used blue light to activate the optobody, but Heo believes he can get the tools to work with infrared light, too. Although there are many types of nanobodies, he believes the tools will work across this antibody class and for many types of questions. The chosen split site is in the antibody’s highly conserved domain.

 

In his lab, says Heo, tool development involves intense testing, which takes a collaborative lab culture. Lab members not involved in a project are a tool’s first users. This arrangement is not easy given his students’ eagerness to publish quickly. But Heo seeks generalizable, broadly applicable tools. “I don’t make very special, very tricky things,” he says, which might only work in a few labs.

 

In his lab, Heo encourages his students to explore projects that intrigue them and that will make them happy during their years in his lab. “If they are not happy with something, I won’t be happy, too.”

 

Heo grew up on a farm in the country. “I didn’t really have the plan to be a professorresearcher at the time,” he says. He played with his dog, rabbit and cows, and was curious about how they interacted and cared for their young. He learned about rice and barley farming. “It’s not textbook, it’s just nature,” he says. In high school, he began breeding birds: peacocks, turkeys, pheasants, parrots and canaries.

 

Even college was not in his plans, but curiosity led him to Gyeongsang National University. “I realized that I had to step up to another level,” he says. Heo studied plant biology and switched to biochemistry in graduate school.

 

For his postdoctoral fellowship, curiosity was again a driver. He wanted to work in mammalian systems, and joined the Duke University lab of Tobias Meyer. Heo followed Meyer to Stanford University where, after a few years, he was promoted to staff researcher. After nine years in California, Heo joined KAIST and chose to focus on optogenetics.

 

Heo feels he can now combine his experience across fields: plant biology, cell biology, cell signaling and neurobiology. As Heo completed his PhD, he remembers realizing that many plant proteins are not present in mammals, which might make them useful tools, he says. This idea has emerged as a cornerstone of optogenetics.

 

Optogenetics has taken cell biology labs beyond observation, which might miss half of the actual cellular events. Cells “are talking to each other, communicating to each other,” he says. The ability to activate or deactivate proteins with light gives labs a way to explore cell biology more deeply and can help them, for example, determine proteins crucial to the cell cycle.

 

“If they are not happy with something, I won’t be happy.”

 

“I admire Won Do’s work for its creativity; he has applied optical control by the cryptochromeCIB1 interaction in very imaginative ways,” says Heo’s friend and colleague, Stanford University researcher Michael Lin. Heo and his students don’t shy away from the hard work necessary to realize their ideas, says Lin. “Developing truly new methods is high-risk and time-consuming, but Won Do has shown that the high rewards make it worth it.”



출처: Nature Methods > This month >

       https://www.nature.com/articles/s41592-019-0626-1


List of Articles
번호 제목 글쓴이 날짜 조회 수
400 [조병관 교수님 연구실] 2022년 안전관리 우수연구실 선정 file 생명과학과 2023.01.27 83
399 [김은준 교수님] 자폐 진단․ 치료 골든타임, 동물실험으로 확인 생명과학과 2022.09.27 158
398 [김보람 박사님(서성배 교수님 연구실)] 한국뇌연구원 제2회 다한우수논문상 선정 생명과학과 2022.12.07 176
397 [정인경 교수님] 기저 질환이 없는 코로나19 환자의 중증 신규 유전적 위험 인자 규명 생명과학과 2022.09.29 177
396 [이승재 교수님] 생체 노화 정도를 측정할 수 있는 새로운 RNA 지표 발견​ 생명과학과 2022.12.08 222
395 [송지준 교수님] 헌팅턴병 발병원인 제거를 위한 치료제 개발 방법 제시​ 생명과학과 2022.09.02 238
394 [메디포럼 정재언 대표] 메디포럼, 정재언 연구소장 신임 대표이사 선임…“임상 R&D 중심 경영 집중” 생명과학과 2022.03.14 246
393 [이승희 교수님] 신경전달물질 소마토스타틴의 알츠하이머 독성 개선효과 발견​ 생명과학과 2022.07.25 268
392 [김은준 교수님] 대규모 한국인 자폐증 가족 유전체 연구를 통한 새로운 자폐 유전변이 최초 발견​ 생명과학과 2022.07.19 273
391 [조병관 교수님] 대량의 고농도 일산화탄소를 고부가가치 바이오케미칼로 전환하는 기술 개발 생명과학과 2022.07.15 288
390 [전상용 교수님] 항암치료용 인공탄수화물 기반 나노의약 개발​ 생명과학과 2022.07.12 289
389 [김세윤, 양한슬 교수님] 장 조직의 항상성과 염증성 장염 회복의 핵심 효소 발견​ 생명과학과 2022.10.07 292
388 [김대수 교수님] 액트노바, 카카오벤처스로부터 5억 규모 시드 투자 유치 "육안으로 진행되던 임상·비임상 분야 행동 실험 과정, 인공지능 영상처리 기술로 자동화" 생명과학과 2022.08.10 304
387 [이승재 교수님 연구실] 과기정통부, ‘2022년도 건강한 연구실’ 10개 선정 생명과학과 2022.12.12 306
386 [김대수 교수님] “뇌는 무언가 실패하는 순간 발달...‘메타인지’로 창의성 키워야” [이노베이트코리아 2022] 생명과학과 2022.07.18 307
385 [이승재 교수님] 건강한 장수를 유도하는 돌연변이 유전자 발굴 생명과학과 2021.11.24 308
384 [김보람 박사님(서성배 교수님 연구실)] 2022년 국가연구개발 우수성과 100선 선정 file 생명과학과 2022.11.09 309
383 [김상규 교수님] 구글도 올라 탄 神으로 가는 길[과학을읽다] 생명과학과 2022.09.07 312
382 [루닛 서범석 대표] 바이오업계 유니콘 기대 루닛, 서범석 '치료 예측 AI' 고도화 박차 생명과학과 2022.04.27 318
381 [오병하 교수님] 오미크론에도 듣는 범용 항체, 국내에서 개발 생명과학과 2022.02.04 321
Board Pagination Prev 1 2 3 4 5 6 7 8 9 10 ... 20 Next
/ 20